The Role of hs Troponin I and NT-proBNP in Predicting Atrial Fibrillation in Patients With Permanent Pacemakers

Recruiting now

Conditions studied: Atrial Fibrillation

In brief

The goal of this clinical trial is to answer the research question whether hs Troponin I and NT-proBNP have a role in detecting atrial fibrillation in patients with pacemakers. Objectives of the study: 1. To survey some risk factors for atrial fibrillation in patients with permanent pacemakers. 2. To determine the role of hs Troponin I and NT-proBNP in predicting new-onset atrial fibrillation within follow-up time. 3. To build a model to predict the prognosis of atrial fibrillation based on the detected subclinical markers related to atrial fibrillation and classic cardiovascular risk factors.

Key facts

Study ID

NCT06174506

Run by

University of Medicine and Pharmacy at Ho Chi Minh City

People needed

300

Starts

2023-12-01

Expected to finish

2026-09-30

Last updated by the study team

2023-12-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is an adult (≥ 18 years old or older)
• There is indication for permanent pacemaker placement and patient agreement to permanent pacemaker placement
• Patient agrees to participate in the study

You may not qualify if…

• Patients had a diagnosis of atrial fibrillation in their past history or atrial fibrillation is discovered at the time of participating in the study
• Severe patients, at risk of death
• Pregnant
• The patient is indicated for surgery
• Patients with eGFR ≤ 30 mL/min/1.73m2
• The patient has a serious infection

Where it is running

• Cho Ray Hospital — Ho Chi Minh City, None Selected, Vietnam (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.